E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/6/2005 in the Prospect News Biotech Daily.

Micrus Endovascular greenshoe exercised in part, lifting IPO to $35.8 million

By Jennifer Chiou

New York, July 6 - Micrus Endovascular Corp. announced its greenshoe was partially exercised, raising the net proceeds of its initial public offering by $2.55 million to $35.8 million.

Micrus Endovascular sold an additional 250,000 shares of common stock at $11.00 per share.

The company priced its IPO June 15 for 3.25 million shares at $11.00 per share, below its estimated range of $12.00 to $14.00 per share. The offering had a 487,500-share greenshoe.

A.G. Edwards was bookrunner and Needham & Co. was co-manager.

The Sunnyvale, Calif.-based company develops and markets implantable and disposable devices for cerebral vascular diseases.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.